- Home
- NSTS vs CNTB Comparison
NSTS vs CNTB Comparison
Compare NSTS & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- CNTB
- Stock Information
- Founded
- NSTS 1921
- CNTB 2012
- Country
- NSTS United States
- CNTB United States
- Employees
- NSTS N/A
- CNTB N/A
- Industry
- NSTS Savings Institutions
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- CNTB Health Care
- Exchange
- NSTS Nasdaq
- CNTB Nasdaq
- Market Cap
- NSTS 59.9M
- CNTB 65.5M
- IPO Year
- NSTS N/A
- CNTB 2021
- Fundamental
- Price
- NSTS $11.35
- CNTB $1.06
- Analyst Decision
- NSTS
- CNTB Strong Buy
- Analyst Count
- NSTS 0
- CNTB 1
- Target Price
- NSTS N/A
- CNTB $8.00
- AVG Volume (30 Days)
- NSTS 5.8K
- CNTB 31.2K
- Earning Date
- NSTS 11-13-2024
- CNTB 09-05-2024
- Dividend Yield
- NSTS N/A
- CNTB N/A
- EPS Growth
- NSTS N/A
- CNTB N/A
- EPS
- NSTS N/A
- CNTB N/A
- Revenue
- NSTS $6,117,000.00
- CNTB $24,116,000.00
- Revenue This Year
- NSTS N/A
- CNTB N/A
- Revenue Next Year
- NSTS N/A
- CNTB $63.90
- P/E Ratio
- NSTS N/A
- CNTB N/A
- Revenue Growth
- NSTS N/A
- CNTB N/A
- 52 Week Low
- NSTS $9.20
- CNTB $0.77
- 52 Week High
- NSTS $11.50
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- NSTS 56.82
- CNTB 46.58
- Support Level
- NSTS $11.21
- CNTB $1.04
- Resistance Level
- NSTS $11.40
- CNTB $1.23
- Average True Range (ATR)
- NSTS 0.09
- CNTB 0.10
- MACD
- NSTS -0.00
- CNTB 0.01
- Stochastic Oscillator
- NSTS 78.95
- CNTB 42.37
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.